Analyst Price Target is $15.86
▲ +286.76% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for AbCellera Biologics in the last 3 months. The average price target is $15.86, with a high forecast of $24.00 and a low forecast of $6.00. The average price target represents a 286.76% upside from the last price of $4.10.
Current Consensus is
Buy
The current consensus among 7 investment analysts is to buy stock in AbCellera Biologics. This Buy consensus rating has held steady for over two years.